Skip to main content

previous disabled Page of 122
and
  1. No Access

    Chapter and Conference Paper

    Combined Influence of Insulin and Glucagon Upon Hepatocytes in Rats with Liver Loss or Viral Injury

    Insulin and glucagon act in synergy to promote hepatic regeneration in eviscerated rats and to enhance survival in mice with viral hepatitis. Relatively low doses of insulin and high doses of glucagon are requ...

    N. L. R. Bucher in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  2. No Access

    Chapter and Conference Paper

    The Role of Glucagon in Amino Acid Homeotasis

    The uptake of amino acids by the liver, the plasma level of glucagon and the insulin to glucagon ratio have an important role in the amino acid homeostasis of man. Evidence that glucagon may be more important ...

    G. F. Cahill Jr., T. T. Aoki in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  3. No Access

    Chapter and Conference Paper

    Modes of action of antimicrobial agents

    This article has traced the development of a strategy for mode of action studies of chemotherapeutic drugs from its blindfolded empirical beginnings to the current state in which it is possible to assign a cat...

    Professor Dr. Fred E. Hahn in Medicinal Chemistry (1977)

  4. No Access

    Chapter and Conference Paper

    Tilorone hydrochloride: The drug profile

    Prof. Dr. Prakash Chandra, Dr. George J. Wright in Medicinal Chemistry (1977)

  5. No Access

    Chapter and Conference Paper

    Regulation of Hepatic Gluconeogenesis by Glucagon in the Rat

    Glucagon (2 × 10−9 M) increased the rates of gluconeogenesis, ureogenesis and ketogenesis by the perfused isolated rat liver. Glucagon to insulin ratios of 2.6 reversed all the metabolic effects induced by the ad...

    M. S. Ayuso-Parrilla, R. Parrilla in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  6. No Access

    Chapter and Conference Paper

    Lowering of Plasma Lipids, The Major Effect of Repeated Glucagon Administration in Rats

    The most prominent long lasting effect of repeated injection of commercial pancreatic glucagon (0.1–30 mg/kg s.c. twice daily) in fed and starving rats is a depression of the major plasma lipids. This lipid-lo...

    F. Gey, H. Georgi, E. Buhler in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  7. No Access

    Chapter and Conference Paper

    Morphologic Study of Glucagon Release

    The authors studied the release of glucagon from isolated pancreatic islets using thin section preparations, freeze-fracture techniques and radioimmunoassay. The evidence strongly suggests that exocytosis is a...

    J.-L. Carpentier, F. Malaisse-Lagae in GLUCAGON: Its Role in Physiology and Clini… (1977)

  8. No Access

    Chapter and Conference Paper

    Syntheses and activity of heteroprostanoids

    Dr. Dieter Orth, Dr. Hans -Eckart Radunz in Medicinal Chemistry (1977)

  9. No Access

    Chapter and Conference Paper

    Metabolic Fuels in the Embryo and the Newborn

    Although insulin and glucagon can be detected on the 11th day of gestation in the rat fetal pancreas, the secretion and biologic action of these hormones do not reach maturity until after the 30th day of postn...

    E. Blázquez in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  10. No Access

    Chapter and Conference Paper

    High Molecular Weight Glucagons from Avian Islets and Fetal Bovine Pancreas

    Extracts of pigeon pancreatic islets and fetal bovine pancreas contain a 9000 dalton and a 69,000 dalton molecule with glucagon-like immunoreactivity. The avian 9000 dalton molecule, purified by gel filtration...

    A. K. Tung in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  11. No Access

    Chapter and Conference Paper

    Glucose Homeostasis in the Newborn

    Measurements of insulin and glucagon secretion by pancreatic islets isolated from rat pups at various times after birth (0 hours to 15 days) indicate a progressive decline in basal insulin release and a progre...

    J. S. Bajaj, K. D. Buchanan in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  12. No Access

    Chapter and Conference Paper

    The Effects of Exogenously Induced Hyperglucagonemia in Insulin-Treated Diabetics

    A recent report that the continuous intravenous infusion of glucagon failed to worsen hyperglycemia in two insulin-treated juvenile diabetics has raised doubts as to the importance of hyperglucagonemia in insu...

    P. Raskin, C. B. Srikant, H. Nakabayashi in GLUCAGON: Its Role in Physiology and Clini… (1977)

  13. No Access

    Chapter and Conference Paper

    Quantification of Plasma Glucagon Immunoreactive Components in Normal and Hyperglucagonemic States

    Chromatography of human and dog plasma on Bio Gel P-30 columns revealed the presence of as many as four glucagon fractions reacting with a “pancreatic glucagon-specific” antiserum (30K). These fractions have a...

    I. Valverde in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  14. No Access

    Chapter and Conference Paper

    The Issues Related to Abnormal A Cell Function in Diabetes Mellitus

    This paper discusses the issues related to abnormal A-cell function in diabetes mellitus, under the following headings: 1) Problems of radioimmunoassay of glucagon; 2) The measurement of plasma levels of gluca...

    K. D. Buchanan, E. R. Trimble in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  15. No Access

    Chapter and Conference Paper

    The Nature of Hyperglucagonemia in Diabetes Mellitus

    The nature of hyperglucagonemia in diabetes mellitus was investigated in diabetic patients and in experimental animals. The following characteristics of diabetic hyperglucagonemia were demonstrated: decreased ...

    K. Nonaka, H. Toyoshima, T. Yoshida in GLUCAGON: Its Role in Physiology and Clini… (1977)

  16. No Access

    Chapter and Conference Paper

    Plasma Immunoreactive Glucagon in Depancreatized Animals

    The basal level of immunoreactive A cell glucagon (GI, as measured with a pancreatic glucagon specific antiserum) and of gut glucagon-like immunoreactive material (gut GLI: calculated as the difference between...

    T. Matsuyama, R. Tanaka, K. Shima, K. Nonaka in GLUCAGON: Its Role in Physiology and Clini… (1977)

  17. No Access

    Chapter and Conference Paper

    Glucagon-Like Materials in Porcine and Rat Intestinal Mucosa

    Extracts of gastrointestinal tissue contain glucagon-like immunoreactive (GLI) materials with molecular weights varying between 2000 and 30,000. Some of them react with antisera specific for the C-terminal, ot...

    J. M. Conlon, K. D. Buchanan, R. F. Murphy in GLUCAGON: Its Role in Physiology and Clini… (1977)

  18. No Access

    Chapter and Conference Paper

    Glucagon Metabolism in Potential Diabetes Mellitus. Studies of Discordant Twins and Patients After Myocardial Infarction

    Plasma glucagon responses to glucose have been restudied in 12 unaffected twins of diabetics after an interval of 5 years and contrasted with 12 normal (N) and 12 diabetic subjects (D). Once more their glucago...

    J. L. Day in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

  19. No Access

    Chapter and Conference Paper

    Role of the Submaxillary Gland and of the Kidney in the Hyperglucagonemia of Eviscerated Rats

    Significant quantities of A cell and total glucagon were found in the systemic blood of eviscerated rats, especially following arginine infusion. These findings and the hyperglucagonemia previously observed in...

    J. C. Dunbar, H. Silverman, E. Kirman in GLUCAGON: Its Role in Physiology and Clini… (1977)

  20. No Access

    Chapter and Conference Paper

    Effect of Long Term Sulfonylurea Therapy on Glucagon Levels in Maturity Onset Diabetes Mellitus

    Glucagon secretion was studied before and after the control of hyperglycemia in 15 maturity onset male diabetics (mean age 56.1 yrs; mean duration of diabetes 7.3 yrs). Optimum control of hyperglycemia was ach...

    S. Podolsky, A. M. Lawrence in GLUCAGON: Its Role in Physiology and Clinical Medicine (1977)

previous disabled Page of 122